Golden, Jeffrey |
TETON, NCT04708782: Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis |
|
|
| Recruiting | 3 | 576 | Canada, US | Placebo, Inhaled Treprostinil, Tyvaso, Treprostinil Ultrasonic Nebulizer | United Therapeutics | Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease | 06/25 | 06/25 | | |
|
|
| Completed | 2 | 80 | Europe, US | Orvepitant Maleate, Placebo | Nerre Therapeutics Ltd., Pharm-Olam International | Cough, Idiopathic Pulmonary Fibrosis | 06/24 | 06/24 | | |
NCT05571059: Oral Ifetroban in Patients with Idiopathic Pulmonary Fibrosis (IPF) |
|
|
| Recruiting | 2 | 128 | US | Ifetroban Sodium, ifetroban, Placebo | Cumberland Pharmaceuticals | Idiopathic Pulmonary Fibrosis | 01/26 | 01/26 | | |
NCT05195918: Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients |
|
|
| Recruiting | 1 | 50 | US | EGCG 300 mg + Nintedanib, epigallocatechin-3-gallate + Ofev, EGCG 300 mg + Pirfenidone, epigallocatechin-3-gallate + Esbriet, Placebo 2 capsules + Nintedanib or Pirfenidone, Placebo + Ofev or Esbriet, EGCG 600 mg + Nintedanib, EGCG 600 mg + Pirfenidone, Placebo 4 capsules + Nintedanib or Pirfenidone | Hal Chapman, University of Michigan, Cornell University, Massachusetts General Hospital, Temple University, University of Washington, University of Virginia | Idiopathic Pulmonary Fibrosis | 04/26 | 04/26 | | |
Fineman, Jeffrey R |
MoD, NCT04039464: Mono vs. Dual Therapy for Pediatric Pulmonary Arterial Hypertension |
|
|
| Recruiting | 3 | 100 | Canada, US | Mono-Therapy with Sildenafil, Revatio monotherapy, Duo-Therapy with Sildenafil + Bosentan, Dual therapy with Revatio and Tracleer | Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI), National Center for Advancing Translational Sciences (NCATS) | Pediatric Pulmonary Hypertension | 09/26 | 09/26 | | |
| Recruiting | N/A | 3000 | US | | Pulmonary Hypertension Association, Inc., University of Washington, the Collaborative Health Studies Coordinating Center | Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Hypertension | 10/25 | 10/25 | | |
| Recruiting | N/A | 2500 | Canada, US | | University of Colorado, Denver, National Heart, Lung, and Blood Institute (NHLBI), Johnson & Johnson | Pulmonary Vascular Disease, Pulmonary Arterial Hypertension | 12/30 | 12/31 | | |
Mandl, Kenneth D |
| Recruiting | N/A | 2500 | Canada, US | | University of Colorado, Denver, National Heart, Lung, and Blood Institute (NHLBI), Johnson & Johnson | Pulmonary Vascular Disease, Pulmonary Arterial Hypertension | 12/30 | 12/31 | | |
Epel, Elissa |
| Not yet recruiting | N/A | 100 | US | Meditation, Mindful Motivation | University of California, San Francisco, Headspace Meditation Limited, National Center for Complementary and Integrative Health (NCCIH), DexCom, Inc. | Binge Eating, Psychological, Health Behavior, Weight, Body | 08/26 | 08/26 | | |
MHIP, NCT05972109: Metabolic Health Improvement Program: Effects of a Workplace Sugary Beverages Sales Ban and Motivational Counseling |
|
|
| Recruiting | N/A | 700 | US | Workplace SSB sales ban, Brief Intervention | University of California, San Francisco, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Sutter Health, California Pacific Medical Center Research Institute | Obesity, Abdominal, Insulin Sensitivity | 10/25 | 10/25 | | |
Cheng, Richard |
MUSIC-HFrEF1, NCT04703842: Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction |
|
|
| Recruiting | 1/2 | 57 | US | SRD-001, Placebo | Sardocor Corp., Covance | Congestive Heart Failure, Heart Failure, Systolic, Heart Failure, HFrEF - Heart Failure With Reduced Ejection Fraction | 12/25 | 12/28 | | |
| Recruiting | N/A | 100 | Europe, Canada, US | Edwards APTURE transcatheter shunt system, Sham procedure | Edwards Lifesciences | Heart Failure | 01/26 | 07/30 | | |
NCT03523416: Early Feasibility Study - Edwards APTURE Transcatheter Shunt System |
|
|
| Active, not recruiting | N/A | 71 | US | Transcatheter Atrial Shunt System | Edwards Lifesciences | Heart Failure | 12/23 | 11/28 | | |
| Recruiting | N/A | 500 | Europe, Canada, US | MitraClip™ device implantation, Mitral Valve Repair Surgery | Abbott Medical Devices | Mitral Valve Regurgitation | 04/26 | 04/34 | | |
NCT03142152: The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR |
|
|
| Recruiting | N/A | 300 | Europe, US | Carillon Mitral Contour System, Carillon, Percutaneous mitral valve repair, Guideline Directed Heart Failure Medication | Cardiac Dimensions, Inc. | Functional Mitral Regurgitation, Heart Failure, Mitral Valve Insufficiency, Heart Diseases, Cardiovascular Diseases, Heart Valve Diseases | 12/26 | 12/30 | | |
Klein, Liviu |
NCT04194632: Right Ventricular Pacing in Pulmonary Arterial Hypertension |
|
|
| Recruiting | N/A | 16 | US | Temporary right ventricular pacing | University of California, San Francisco | Pulmonary Artery Hypertension, Right Ventricular Dysfunction | 12/21 | 12/21 | | |
DETECT-HF, NCT06378632: AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM |
|
|
| Recruiting | N/A | 500 | Europe, US, RoW | Hearo App | Cordio Medical | Heart Failure | 01/25 | 03/25 | | |
| Recruiting | N/A | 80 | US | Satera GSN Ablation, Sham Control | Axon Therapies, Inc. | Heart Failure With Preserved Ejection Fraction | 04/22 | 03/23 | | |
NCT04223934: Tailored Drug Titration Using Artificial Intelligence |
|
|
| Completed | N/A | 164 | US | optima4BP | Optima Integrated Health, University of California, San Francisco | Hypertension | 12/22 | 06/23 | | |
| Recruiting | N/A | 20 | US | Silverlon, Control | University of California, San Francisco, International Consortium of Circulatory Assist Clinicians | LVAD (Left Ventricular Assist Device) Driveline Infection | 12/23 | 12/23 | | |
| Recruiting | N/A | 30 | US | Doraya Catheter | Revamp Medical Inc. | Acute Decompensated Heart Failure | 10/25 | 12/25 | | |
CorCinch-HF, NCT04331769: Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present with Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF): the CORCINCH-HF Study |
|
|
| Recruiting | N/A | 400 | Europe, US, RoW | AccuCinch Ventricular Restoration System, Guideline-Directed Medical Therapy | Ancora Heart, Inc. | Heart Failure with Reduced Ejection Fraction (HFrEF), Dilated Cardiomyopathy | 12/26 | 12/30 | | |
| Recruiting | N/A | 372 | US | Aquadex Smartflow® System, IV Loop Diuretics | Nuwellis, Inc. | Heart Failure (for Example, Fluid Overload) | 07/25 | 10/25 | | |
NCT03523416: Early Feasibility Study - Edwards APTURE Transcatheter Shunt System |
|
|
| Active, not recruiting | N/A | 71 | US | Transcatheter Atrial Shunt System | Edwards Lifesciences | Heart Failure | 12/23 | 11/28 | | |
| Active, not recruiting | N/A | 350 | US | OCS Heart System | TransMedics | Transplant | 12/25 | 12/29 | | |
ReDS-HF, NCT03586336: Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure |
|
|
| Recruiting | N/A | 100 | US | ReDS-Guided, Usual Care | University of California, San Francisco, Sensible Medical Innovations Ltd. | Heart Failure; With Decompensation | 12/25 | 12/25 | | |
| Recruiting | N/A | 500 | Europe, US | remede System | Respicardia, Inc. | Central Sleep Apnea | 06/27 | 06/32 | | |
| Recruiting | N/A | 100000 | US | OCS Heart | TransMedics | Heart Transplant | 08/29 | 08/33 | | |
Rosenzweig, Erika |
| Recruiting | N/A | 3000 | US | | Pulmonary Hypertension Association, Inc., University of Washington, the Collaborative Health Studies Coordinating Center | Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Hypertension | 10/25 | 10/25 | | |
| Recruiting | N/A | 2500 | Canada, US | | University of Colorado, Denver, National Heart, Lung, and Blood Institute (NHLBI), Johnson & Johnson | Pulmonary Vascular Disease, Pulmonary Arterial Hypertension | 12/30 | 12/31 | | |
Varghese, Nidhy |
MoD, NCT04039464: Mono vs. Dual Therapy for Pediatric Pulmonary Arterial Hypertension |
|
|
| Recruiting | 3 | 100 | Canada, US | Mono-Therapy with Sildenafil, Revatio monotherapy, Duo-Therapy with Sildenafil + Bosentan, Dual therapy with Revatio and Tracleer | Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI), National Center for Advancing Translational Sciences (NCATS) | Pediatric Pulmonary Hypertension | 09/26 | 09/26 | | |
| Recruiting | N/A | 3000 | US | | Pulmonary Hypertension Association, Inc., University of Washington, the Collaborative Health Studies Coordinating Center | Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Hypertension | 10/25 | 10/25 | | |
| Recruiting | N/A | 2500 | Canada, US | | University of Colorado, Denver, National Heart, Lung, and Blood Institute (NHLBI), Johnson & Johnson | Pulmonary Vascular Disease, Pulmonary Arterial Hypertension | 12/30 | 12/31 | | |
Nguyen, Cassie |
| Recruiting | N/A | 372 | US | Aquadex Smartflow® System, IV Loop Diuretics | Nuwellis, Inc. | Heart Failure (for Example, Fluid Overload) | 07/25 | 10/25 | | |
| Recruiting | N/A | 100 | Europe, Canada, US | Edwards APTURE transcatheter shunt system, Sham procedure | Edwards Lifesciences | Heart Failure | 01/26 | 07/30 | | |
NCT03523416: Early Feasibility Study - Edwards APTURE Transcatheter Shunt System |
|
|
| Active, not recruiting | N/A | 71 | US | Transcatheter Atrial Shunt System | Edwards Lifesciences | Heart Failure | 12/23 | 11/28 | | |
| Active, not recruiting | N/A | 350 | US | OCS Heart System | TransMedics | Transplant | 12/25 | 12/29 | | |
ReDS-HF, NCT03586336: Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure |
|
|
| Recruiting | N/A | 100 | US | ReDS-Guided, Usual Care | University of California, San Francisco, Sensible Medical Innovations Ltd. | Heart Failure; With Decompensation | 12/25 | 12/25 | | |
| Recruiting | N/A | 100000 | US | OCS Heart | TransMedics | Heart Transplant | 08/29 | 08/33 | | |
Hopper, Rachel |
| Recruiting | N/A | 2500 | Canada, US | | University of Colorado, Denver, National Heart, Lung, and Blood Institute (NHLBI), Johnson & Johnson | Pulmonary Vascular Disease, Pulmonary Arterial Hypertension | 12/30 | 12/31 | | |